SACM1L Antibody

What is SACM1L and What are its Key Biological Functions?

SACM1L (also known as SAC1, Suppressor of actin mutations 1-like protein) is a phosphoinositide phosphatase that primarily catalyzes the hydrolysis of phosphatidylinositol 4-phosphate (PtdIns(4)P). It also demonstrates activity toward phosphatidylinositol 3-phosphate (PtdIns(3)P) and exhibits low activity against phosphatidylinositol-3,5-bisphosphate (PtdIns(3,5)P2) .

SACM1L localizes in the cytoplasm and membrane systems of the endoplasmic reticulum and Golgi apparatus where it performs its enzymatic activities. Its primary function is ensuring proper turnover of phosphatidylinositides, which is critical for membrane identity and function in transport processes .

Recent research has revealed that SACM1L plays an important role in:

• Restricting intracellular bacterial replication

• Regulating autophagosomal phosphatidylinositol-4-phosphate

• Promoting fusion of Salmonella-containing autophagosomes with lysosomes

What Applications are SACM1L Antibodies Suitable For?

SACM1L antibodies have been validated for multiple laboratory applications with varying degrees of effectiveness depending on the specific antibody:

The observed molecular weight of SACM1L in experimental conditions is typically between 60-67 kDa, which closely matches its calculated molecular weight of 67 kDa .

How Should I Design Control Experiments When Using SACM1L Antibodies?

When designing experiments with SACM1L antibodies, implementing proper controls is critical for ensuring result validity:

Positive Controls:

• Use tissues/cells known to express SACM1L (validated examples include human kidney tissue, A549 cells, mouse kidney/lung tissue, and human brain tissue)

• Include recombinant SACM1L protein or SACM1L-overexpressing cells

Negative Controls:

• SACM1L knockout (KO) cell lines created using CRISPR-Cas9 system (as described in published studies)

• Primary antibody omission

• Isotype control antibodies

• Peptide blocking experiments using the immunizing peptide

Validation Experiments:

• Compare results using multiple antibodies targeting different epitopes of SACM1L

• Validate specificity through siRNA knockdown experiments

• For colocalization studies, use dual staining with antibodies against known organelle markers (ER/Golgi markers)

What are the Critical Parameters for Optimizing Western Blot Protocols with SACM1L Antibodies?

Optimizing Western blot protocols for SACM1L detection requires attention to several critical parameters:

Sample Preparation:

• Use RIPA or NP-40 based lysis buffers with protease inhibitors

• Include phosphatase inhibitors if phosphorylation states are important

• Recommended protein loading: 20-50 μg of total protein per lane

Gel Electrophoresis and Transfer:

• 8-10% SDS-PAGE gels are optimal for resolving the 60-67 kDa SACM1L protein

• Semi-dry or wet transfer systems both work effectively

• Transfer time: 60-90 minutes at 100V in cold room conditions

Antibody Incubation:

• Primary antibody dilution: Start with manufacturer's recommendation (typically 1:500-1:2000)

• Incubate at 4°C overnight for optimal signal-to-noise ratio

• Secondary antibody: HRP-conjugated anti-rabbit IgG (1:5000-1:10000)

Detection and Troubleshooting:

• If multiple bands appear, validate using knockout controls

• Some antibodies detect SACM1L at slightly different molecular weights (60-67 kDa range)

• High background may require more stringent blocking (5% BSA often preferred over milk)

How Can I Design Experiments to Study SACM1L's Role in Autophagy?

Research has established SACM1L's role in autophagosome maturation and bacterial restriction through autophagy. When designing experiments to study this function:

Experimental Approaches:

• LC3 Conversion Assay:

  • Compare LC3-I to LC3-II conversion in wild-type versus SACM1L knockout cells

  • Assess under basal conditions and in response to autophagy inducers (Torin1) or inhibitors (Bafilomycin A1)

• Tandem mCherry-GFP-LC3 Reporter System:

  • Establish stable expression in wild-type and SACM1L KO cells

  • Quantify mCherry+GFP+ (immature autophagosomes) versus mCherry+GFP- (acidified autolysosomes)

  • This distinguishes between autophagosome formation and maturation defects

• Bacterial Infection Models:

  • Infect cells with Salmonella Typhimurium to study xenophagy

  • Measure bacterial replication through CFU counts or bioluminescence

  • Assess colocalization of bacteria with autophagy markers (LC3) and lysosomal markers (LAMP1)

• Rescue Experiments:

  • Re-express wild-type SACM1L or catalytically dead mutants (e.g., C389S)

  • Determine if phosphatase activity is required for specific functions

Controls and Validation:

• Include phosphoinositide-binding probes to monitor PI(4)P and PI(3)P levels

• Use lysosomal function assays (LysoTracker, DQ-BSA) to differentiate between autophagy and lysosomal defects

What are the Best Practices for Immunostaining SACM1L in Different Cell Types?

Optimizing immunostaining protocols for SACM1L requires consideration of its subcellular localization and expression levels in different cell types:

Fixation Methods:

• 4% paraformaldehyde (10-15 minutes at room temperature) works well for most applications

• For specific organelle localization, combine with 0.1% glutaraldehyde

• Methanol fixation (-20°C for 10 minutes) may better preserve membrane structures

Permeabilization Options:

• 0.1-0.2% Triton X-100 in PBS (5-10 minutes) for general applications

• 0.1% saponin for more gentle permeabilization that better preserves membrane structures

Antibody Incubation Parameters:

• Primary antibody dilution: 1:50-1:500 as recommended by manufacturers

• Incubate overnight at 4°C for optimal staining

• Secondary antibody: Alexa Fluor-conjugated anti-rabbit IgG (1:500-1:1000)

Cell Type-Specific Considerations:

• A549 cells show reliable SACM1L staining and are recommended as positive controls

• Primary cells may require optimized permeabilization and antibody concentrations

• For tissues, antigen retrieval with TE buffer (pH 9.0) is recommended

Colocalization Studies:

• Pair with markers for ER (calnexin, PDI), Golgi (GM130), or autophagosomes (LC3)

• Use super-resolution microscopy for precise localization

• Include dual labeling with phosphoinositide probes

How Can SACM1L Knockout/Knockdown Models Be Generated and Validated?

Several approaches have been used successfully to generate SACM1L-deficient cellular models:

CRISPR-Cas9 Knockout:

• Target early exons for complete protein loss

• Verify genomic editing by sequencing

• Confirm protein loss by Western blot with antibodies targeting different epitopes

• Published studies have established SACM1L knockout HeLa cell lines using this approach

siRNA/shRNA Knockdown:

• Multiple siRNAs targeting different regions of SACM1L mRNA should be tested

• Recommended siRNA concentration: 20-50 nM for transient knockdown

• Validate knockdown efficiency by qRT-PCR (mRNA level) and Western blot (protein level)

• Assess for off-target effects using rescue experiments

Phenotype Validation:

• Analyze Golgi morphology (typically dispersed in SACM1L-deficient cells)

• Measure phosphoinositide levels using specific probes

• Assess autophagy flux and bacterial replication

• Compare phenotypes between knockout and knockdown models to rule out compensation

Rescue Experiments:

• Re-express wild-type SACM1L to confirm phenotype specificity

• Test phosphatase-dead mutants (C389S) to determine enzymatic requirements

• Use localization mutants to assess compartment-specific functions

What Are Common Pitfalls in SACM1L Antibody-Based Experiments and How to Overcome Them?

Several challenges are commonly encountered when working with SACM1L antibodies:

Cross-Reactivity Issues:

• Some antibodies may cross-react with related phosphatases

• Validate specificity using knockout controls

• Consider using multiple antibodies targeting different epitopes

• Pre-adsorb antibodies with recombinant related proteins if necessary

Subcellular Localization Discrepancies:

• SACM1L has been reported in both ER and Golgi compartments

• Fixation methods can affect apparent localization

• Use cell fractionation followed by Western blot to confirm biochemical localization

• Employ super-resolution microscopy for precise localization studies

Inconsistent Western Blot Results:

• SACM1L can appear as multiple bands due to post-translational modifications

• Sample preparation conditions affect band pattern

• Use phosphatase inhibitors if studying phosphorylated forms

• Include both reducing and non-reducing conditions if disulfide bonds are suspected

Batch-to-Batch Variability:

• Antibody performance can vary between lots

• Validate each new lot against previous standards

• Maintain reference samples as controls

• Consider monoclonal antibodies for critical applications requiring long-term consistency

How Can I Design Experiments to Study SACM1L's Role in Phosphoinositide Metabolism?

SACM1L's primary function as a phosphoinositide phosphatase requires specialized approaches:

Phosphoinositide Level Measurement:

• Radiolabeling with [³H]inositol followed by HPLC analysis

• Mass spectrometry-based lipidomics for comprehensive profiling

• Fluorescent/luminescent biosensors for live cell imaging of PI(4)P and PI(3)P

In Vitro Phosphatase Assays:

• Purify recombinant SACM1L protein (wild-type and catalytic mutants)

• Use synthetic phosphoinositide substrates (PI(4)P, PI(3)P, PI(3,5)P2)

• Measure phosphate release using malachite green assay

• Test activity in different membrane contexts (liposomes of varying composition)

Cellular Phosphoinositide Dynamics:

• Express genetically encoded phosphoinositide biosensors

• Perform live imaging during manipulation of SACM1L levels

• Develop drug-inducible SACM1L systems for acute manipulation

• Monitor organelle-specific pools using targeted biosensors

Substrate Specificity Studies:

• Compare hydrolysis rates of different phosphoinositides

• Determine the effect of membrane composition on activity

• Assess 'cis' versus 'trans' activity as reported in the literature

• Investigate regulation by interacting proteins like PLEKHA3

What are Advanced Applications of SACM1L Antibodies in Infection and Immunity Research?

Recent research has uncovered SACM1L's role in host-pathogen interactions:

Xenophagy Studies:

• Monitor colocalization of bacteria with autophagy markers in SACM1L-deficient cells

• Visualize LC3+LAMP1+ bacteria in wild-type versus SACM1L knockout cells

• Track bacterial metabolic activity using inducible reporter systems (e.g., IPTG-inducible mCherry)

• Assess bacterial survival in different cellular compartments

Advanced Imaging Techniques:

• Live cell imaging to track bacterial fate in real-time

• Super-resolution microscopy to precisely locate SACM1L at membrane contact sites

• Correlative light-electron microscopy to visualize autophagosomal ultrastructure

Experimental Infection Models:

• Beyond Salmonella, test other intracellular pathogens (Mycobacteria, Listeria)

• Develop in vivo models using conditional SACM1L knockout animals

• Assess tissue-specific responses in infection models

• Explore SACM1L's role in immune cell function (macrophages, dendritic cells)

Therapeutic Implications:

• Screen for compounds that modulate SACM1L activity

• Investigate whether pathogens directly target SACM1L function

• Explore genetic variations in SACM1L and susceptibility to infection

• Develop cell-based assays to screen antimicrobial compounds based on SACM1L function

The combination of these advanced approaches has revealed that SACM1L restricts intracellular bacterial replication by controlling PI(4)P on Salmonella-containing autophagosomes, demonstrating an important connection between phosphoinositide metabolism and antibacterial autophagy .

How Should I Interpret Conflicting Results When Using Different SACM1L Antibodies?

When faced with discrepancies between experiments using different SACM1L antibodies:

Systematic Analysis of Antibody Characteristics:

• Compare epitope locations (N-terminal, C-terminal, internal domains)

• Assess antibody formats (polyclonal vs. monoclonal)

• Review validation data from manufacturers and literature

• Consider species cross-reactivity profiles

Technical Validation Strategy:

• Side-by-Side Comparison:

  • Run parallel experiments with multiple antibodies

  • Use identical samples, protocols, and detection methods

  • Include positive and negative controls (especially SACM1L knockout cells)

• Complementary Approaches:

  • Validate with non-antibody methods (e.g., tagged SACM1L expression)

  • Use RNA-level detection (qPCR, RNA-seq) to correlate with protein data

  • Apply orthogonal techniques (mass spectrometry) for unbiased detection

• Specific Conflict Resolution:

  • For subcellular localization conflicts: perform fractionation followed by Western blot

  • For molecular weight discrepancies: analyze post-translational modifications

  • For signal intensity variations: titrate antibody concentrations and optimize protocols

Interpretation Framework:

• Consider that different antibodies may recognize different SACM1L isoforms or modified forms

• Evaluate whether results align with known SACM1L biology

• Look for consensus patterns across multiple antibodies

• Report all discrepancies transparently in publications

What Methods Can Be Used to Study SACM1L Protein-Protein Interactions?

Understanding SACM1L's interactome is crucial for elucidating its regulatory mechanisms:

Immunoprecipitation-Based Approaches:

• Standard IP using validated SACM1L antibodies (optimization required: 0.5-4.0 μg antibody per 1.0-3.0 mg lysate)

• Co-IP followed by Western blot for candidate interactors

• IP-mass spectrometry for unbiased interactome analysis

• Proximity-dependent biotin identification (BioID) using SACM1L-BirA fusion proteins

Advanced Interaction Mapping:

• FRET/BRET assays for studying direct interactions in living cells

• Split-luciferase complementation assays

• Yeast two-hybrid screening

• Protein fragment complementation assays

Context-Specific Interactions:

• Membrane-specific interaction studies using liposome flotation assays

• Crosslinking mass spectrometry for mapping interaction interfaces

• Subcellular fractionation before IP to identify compartment-specific interactors

• Stimulus-dependent interaction studies (e.g., during infection or stress conditions)

Validation Strategies:

• Reciprocal co-IP experiments

• Domain mapping using truncation mutants

• Competition assays with purified proteins

• Functional validation through mutational analysis

Published studies have identified interactions between SACM1L and proteins like PLEKHA3, which enhances its PtdIns(4)P phosphatase activity . Additionally, 14-3-3 proteins facilitate SAC1 transport from the endoplasmic reticulum .

How Can SACM1L Function Be Measured in Different Subcellular Compartments?

SACM1L functions at multiple membrane interfaces, requiring compartment-specific analysis methods:

Organelle-Specific Activity Measurement:

• Subcellular fractionation followed by in vitro phosphatase assays

• Targeted optogenetic recruitment of SACM1L to specific organelles

• Compartment-specific phosphoinositide sensors to monitor local activity

• Reconstitution of SACM1L activity in artificial membrane systems

Visualization Techniques:

• Organelle-specific GFP-tagged SACM1L constructs

• Correlative light and electron microscopy to precisely localize SACM1L

• Super-resolution microscopy to visualize SACM1L at membrane contact sites

• Multi-color live imaging to track SACM1L dynamics between compartments

Functional Readouts:

• Membrane trafficking assays (VSVG transport, transferrin recycling)

• Organelle morphology analysis (particularly Golgi structure)

• Calcium signaling as an indirect measure of ER-PM contact site function

• Autophagosome maturation measured by tandem fluorescent LC3

Experimental Design Considerations:

• Include organelle-specific markers in all imaging experiments

• Use drug-inducible targeting systems for acute recruitment

• Compare 'cis' versus 'trans' activity using appropriate membrane tethering

• Incorporate membrane tension/curvature variables into analysis

Research indicates that SACM1L exhibits robust PtdIns(4)P phosphatase activity when binding its substrate in a 'cis' configuration within the cellular environment, with significantly less activity when binding in a 'trans' configuration .

What are the Most Sensitive Detection Methods for Low-Abundance SACM1L Expression?

When studying tissues or cells with low SACM1L expression levels:

Enhanced Western Blot Techniques:

• Signal amplification using HRP-conjugated polymers instead of standard secondary antibodies

• Chemiluminescent substrates with extended signal duration

• Digital imaging systems with high sensitivity settings

• Sample concentration methods (immunoprecipitation before Western blot)

Advanced Immunohistochemistry Approaches:

• Tyramide signal amplification (TSA) for 10-100× signal enhancement

• Polymer-based detection systems

• Optimized antigen retrieval with TE buffer (pH 9.0) as recommended

• Sequential antibody layering techniques

Single-Cell Analysis Methods:

• Flow cytometry with intracellular staining optimization

• Mass cytometry (CyTOF) for multiplexed protein detection

• Single-cell Western blot technologies

• Proximity ligation assay (PLA) for detecting protein interactions with enhanced sensitivity

Molecular-Level Detection:

• Droplet digital PCR for absolute quantification of SACM1L mRNA

• RNAscope for visualizing mRNA with single-molecule resolution

• Highly sensitive ELISA development using sandwich approach

• Targeted mass spectrometry using parallel reaction monitoring

When using these enhanced methods, appropriate controls become even more critical to distinguish specific signal from background or artifacts.

How Can I Design Experiments to Study SACM1L's Function in Disease Models?

SACM1L's role in membrane trafficking and bacterial defense suggests potential relevance in various disease contexts:

Neurodegenerative Disease Models:

• Analyze SACM1L expression and localization in Alzheimer's, Parkinson's, or ALS models

• Assess autophagy flux in neuronal cells with SACM1L manipulation

• Study phosphoinositide dysregulation in disease-relevant contexts

• Evaluate membrane trafficking defects in patient-derived neurons

Experimental Design for Infectious Disease:

• Beyond Salmonella, test SACM1L's role in defense against other intracellular pathogens

• Develop tissue-specific knockout models to assess organ-specific vulnerability

• Screen for pathogen factors that may target SACM1L function

• Correlate SACM1L genetic variants with infection outcomes

Cancer Research Applications:

• Analyze SACM1L expression in tumor samples versus normal tissues

• Investigate autophagy dependency in cancer cells with SACM1L modulation

• Explore SACM1L's role in cancer cell migration and invasion

• Assess Golgi structure and secretory pathway activity in metastatic models

Methodological Considerations:

• Use disease-relevant cell types (primary cells, iPSC-derived cells)

• Incorporate physiologically relevant stressors

• Consider acute versus chronic SACM1L modulation

• Develop quantitative phenotypic assays relevant to disease mechanisms

These approaches can reveal novel roles for SACM1L in disease pathogenesis and potentially identify new therapeutic strategies targeting phosphoinositide metabolism.

What are the Critical Parameters for Validating the Specificity of a SACM1L Antibody?

Establishing antibody specificity is fundamental to obtaining reliable results:

Essential Validation Experiments:

Advanced Validation Strategies:

• Phosphatase treatment of samples to assess potential phospho-specificity

• Mass spectrometry verification of immunoprecipitated proteins

• Immunodepletion experiments to confirm signal specificity

• Heterologous expression in cells naturally lacking SACM1L

Application-Specific Validation:

• For WB: Molecular weight correlation and band pattern analysis

• For IHC/ICC: Pattern consistency with known localization

• For IP: Mass spectrometry confirmation of pulled-down proteins

• For ELISA: Standard curve with recombinant protein and detection limits

Documentation Requirements:

• Record complete validation experiments for each application

• Document lot-to-lot validation when receiving new antibody batches

• Maintain detailed protocols that maximize specificity

• Include representative validation data in publications

How Can I Quantitatively Assess SACM1L's Impact on Membrane Trafficking?

SACM1L's role in phosphoinositide metabolism affects multiple membrane trafficking processes:

Golgi Trafficking Assays:

• VSV-G transport assay (temperature-sensitive mutant) to measure ER-to-Golgi and Golgi-to-plasma membrane trafficking

• Quantitative analysis of Golgi morphology using automated image analysis

• RUSH (Retention Using Selective Hooks) system for synchronized cargo release

• Quantification of secreted proteins using pulse-chase experiments

Endocytic Pathway Analysis:

• Transferrin uptake and recycling kinetics

• Endosomal maturation tracked with Rab conversion markers

• EGF receptor degradation assays

• Quantitative co-localization with endosomal markers (EEA1, Rab5, Rab7)

Autophagy Flux Measurement:

• LC3-II/LC3-I ratio quantification with and without lysosomal inhibitors

• Tandem fluorescent LC3 reporter analysis using automated image quantification

• Long-lived protein degradation assays

• Selective substrate degradation (p62/SQSTM1 levels)

Advanced Quantitative Approaches:

• High-content screening with multiple trafficking markers

• Live-cell trafficking kinetics using photoactivatable cargo

• Correlative light-electron microscopy for ultrastructural quantification

• Mathematical modeling of membrane trafficking dynamics

These quantitative assays can reveal subtle defects in membrane trafficking pathways that might be missed with qualitative assessments alone.

What are the Key Considerations When Using SACM1L Antibodies for Immunoprecipitation?

Immunoprecipitation (IP) of SACM1L requires optimization for maximum specificity and efficiency:

Buffer Optimization:

• Standard lysis buffers (RIPA, NP-40) may disrupt membrane associations

• Consider gentler detergents (0.5-1% digitonin, 1% CHAPS) to preserve interactions

• Include phosphatase inhibitors to maintain phosphorylation states

• Test pH ranges (6.8-7.5) for optimal antibody-antigen interaction

Antibody Selection and Application:

• Validate IP-grade antibodies specifically (not all WB antibodies work for IP)

• Recommended antibody amount: 0.5-4.0 μg for 1.0-3.0 mg of total protein lysate

• Pre-clear lysates to reduce non-specific binding

• Consider direct bead conjugation for cleaner results

Controls and Validation:

• Include IgG control matched to host species

• Perform IP from SACM1L knockout/knockdown cells as negative control

• Validate IP efficiency by quantifying depleted versus bound fractions

• For co-IP, validate with reciprocal IP when possible

Advanced IP Applications:

• Cross-linking IP for capturing transient interactions

• IP followed by mass spectrometry for interactome analysis

• IP of tagged SACM1L compared with endogenous protein

• IP under different cellular conditions (starvation, infection, stress)

Successful IP experiments can identify novel SACM1L-interacting proteins and provide insights into its regulatory mechanisms.

How Can I Design Experiments to Study the Regulation of SACM1L Activity?

SACM1L activity is likely regulated through multiple mechanisms that require specialized experimental approaches:

Post-translational Modification Analysis:

• Phosphorylation site mapping using phospho-specific antibodies or mass spectrometry

• Ubiquitination analysis through ubiquitin pulldowns or specific antibodies

• Palmitoylation assessment using click chemistry approaches

• In vitro modification assays to determine effects on enzymatic activity

Protein Interaction-Based Regulation:

• Screen for proteins that modulate SACM1L activity (e.g., PLEKHA3)

• Investigate regulatory proteins that control SACM1L localization (e.g., 14-3-3)

• Develop in vitro reconstitution systems to test direct regulation

• Map interaction domains through mutagenesis

Metabolic and Stress Regulation:

• Assess SACM1L activity under nutrient starvation conditions

• Evaluate responses to ER stress, oxidative stress, and infection

• Test regulation by cellular energy status (AMPK pathway)

• Investigate calcium-dependent regulatory mechanisms

Membrane Context Regulation:

• Analyze how membrane composition affects SACM1L activity

• Study regulation at membrane contact sites

• Assess influence of membrane curvature or tension

• Investigate substrate presentation ('cis' versus 'trans' activity)

Understanding these regulatory mechanisms will provide insights into how cells control phosphoinositide metabolism in response to different stimuli and conditions.

What Novel Approaches Can Be Used to Study SACM1L Function Beyond Traditional Antibody-Based Methods?

To complement antibody-based studies, several innovative approaches can provide deeper insights into SACM1L biology:

CRISPR-Based Approaches:

• CRISPRi/CRISPRa for tunable gene expression modulation

• CRISPR base editors for introducing specific point mutations

• CRISPR screens to identify genetic interactions

• Endogenous tagging using CRISPR knock-in strategies

Optogenetic and Chemogenetic Tools:

• Light-inducible SACM1L recruitment to specific membrane compartments

• Rapidly inducible degradation systems (AID, dTAG)

• Split constructs for inducing dimerization of SACM1L fragments

• Engineered allosteric switches to control SACM1L activity

Advanced Imaging Technologies:

• Lattice light-sheet microscopy for 4D imaging of SACM1L dynamics

• FRET-based activity sensors for live phosphoinositide monitoring

• Super-resolution microscopy coupled with expansion microscopy

• Cryo-electron tomography of membrane contact sites

Computational and Modeling Approaches:

• Molecular dynamics simulations of SACM1L-membrane interactions

• Reaction-diffusion models of phosphoinositide metabolism

• Machine learning analysis of high-content screening data

• Systems biology approaches to integrate SACM1L into phosphoinositide networks